Duquesne Family Office - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.

Quarter-by-quarter ownership
Duquesne Family Office ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$3,035
-28.8%
659,7500.0%0.11%
-26.4%
Q2 2023$4,262
-14.3%
659,7500.0%0.15%
-31.5%
Q1 2023$4,975
-99.9%
659,7500.0%0.22%
-34.7%
Q4 2022$6,683,268
+2.4%
659,7500.0%0.33%
-10.5%
Q3 2022$6,525,000
-7.1%
659,7500.0%0.37%
-27.2%
Q2 2022$7,026,000
+9.2%
659,7500.0%0.51%
+82.1%
Q1 2022$6,433,000
-31.8%
659,7500.0%0.28%
-18.4%
Q4 2021$9,434,000
-28.6%
659,7500.0%0.34%
-20.3%
Q3 2021$13,221,000
-41.0%
659,7500.0%0.43%
-13.3%
Q1 2021$22,405,000
-15.6%
659,7500.0%0.50%
-30.8%
Q4 2020$26,548,000659,7500.72%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DCVC Bio GP, LLC 29,411$313,000100.00%
Founders Fund VII Management, LLC 3,773,530$40,188,00093.02%
Gruss & Co., LLC 363,778$3,874,00026.99%
Founders Fund Growth Management, LLC 407,017$4,334,00012.66%
GUARDIAN CAPITAL ADVISORS LP 3,836,414$44,387,0005.09%
HARVARD MANAGEMENT CO INC 4,105,095$43,719,0005.06%
Intellectus Partners, LLC 1,089,755$11,606,0003.99%
ArchPoint Investors 630,326$6,713,0002.66%
BRANDYWINE MANAGERS, LLC 56,976$607,0001.49%
Orbimed Advisors 4,180,768$44,525,0000.81%
View complete list of ABCELLERA BIOLOGICS INC shareholders